PT2373652E - Piperidina espiro pirrolidinonas e piperidinonas substituídas utilizadas como moduladores de h3 - Google Patents

Piperidina espiro pirrolidinonas e piperidinonas substituídas utilizadas como moduladores de h3 Download PDF

Info

Publication number
PT2373652E
PT2373652E PT97936496T PT09793649T PT2373652E PT 2373652 E PT2373652 E PT 2373652E PT 97936496 T PT97936496 T PT 97936496T PT 09793649 T PT09793649 T PT 09793649T PT 2373652 E PT2373652 E PT 2373652E
Authority
PT
Portugal
Prior art keywords
piperidinones
modulators
substituted piperidine
piperidine spiro
pyrrolidinone
Prior art date
Application number
PT97936496T
Other languages
English (en)
Inventor
Zhongli Gao
Daniel Hall
Ryan Hartung
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of PT2373652E publication Critical patent/PT2373652E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
PT97936496T 2008-12-05 2009-12-04 Piperidina espiro pirrolidinonas e piperidinonas substituídas utilizadas como moduladores de h3 PT2373652E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12008808P 2008-12-05 2008-12-05
FR0955431 2009-07-31

Publications (1)

Publication Number Publication Date
PT2373652E true PT2373652E (pt) 2014-01-16

Family

ID=41647030

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97936496T PT2373652E (pt) 2008-12-05 2009-12-04 Piperidina espiro pirrolidinonas e piperidinonas substituídas utilizadas como moduladores de h3

Country Status (24)

Country Link
US (2) US8227481B2 (pt)
EP (1) EP2373652B1 (pt)
JP (1) JP5538421B2 (pt)
KR (1) KR101687216B1 (pt)
CN (1) CN102239168B (pt)
AR (1) AR074466A1 (pt)
AU (1) AU2009322248B2 (pt)
CA (1) CA2745721C (pt)
CO (1) CO6390058A2 (pt)
CR (1) CR20110294A (pt)
DK (1) DK2373652T3 (pt)
EC (1) ECSP11011108A (pt)
ES (1) ES2441221T3 (pt)
IL (1) IL213290A (pt)
MA (1) MA32943B1 (pt)
MX (1) MX2011004939A (pt)
NZ (1) NZ593151A (pt)
PE (1) PE20120261A1 (pt)
PT (1) PT2373652E (pt)
RU (1) RU2011127401A (pt)
TN (1) TN2011000233A1 (pt)
TW (1) TWI481609B (pt)
WO (1) WO2010065803A1 (pt)
ZA (1) ZA201103448B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR074467A1 (es) 2008-12-05 2011-01-19 Sanofi Aventis Tetrahidropiran espiro pirrolidinonas y piperidinonas sustituidas, composiciones farmaceuticas que las contienen y uso de las mismas en el tratamiento y/o prevencion de enfermedades del snc ,tales como alzheimer y parkinson, entre otras.
EP2569303A1 (en) 2010-05-11 2013-03-20 Sanofi Substituted n-alkyl and n-acyl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof
JP5784110B2 (ja) 2010-05-11 2015-09-24 サノフイ 置換されたｎ−ヘテロアリールテトラヒドロ−イソキノリン誘導体、その製造及び治療上の使用
EP2569296A1 (en) * 2010-05-11 2013-03-20 Sanofi Substituted n-phenyl spirolactam bipyrrolidines, preparation and therapeutic use thereof
AR081383A1 (es) 2010-05-11 2012-08-29 Sanofi Aventis N-heteroaril bipirrolidin carboxamidas sustituidas, composiciones farmaceuticas que las contienen y uso de las mismas para el tratamiento de enfermedades del sistema nervioso central.
TW201206939A (en) 2010-05-11 2012-02-16 Sanofi Aventis Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof
TW201202251A (en) * 2010-05-11 2012-01-16 Sanofi Aventis Substituted N-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof
JP2013529198A (ja) 2010-05-11 2013-07-18 サノフイ 置換されたｎ−ヘテロシクロアルキルビピロリジニルフェニルアミド誘導体、その製造及び治療上の使用
EP2906542B1 (en) * 2012-10-11 2019-08-07 Merck Sharp & Dohme Corp. Substituted spiropiperidinyl compounds useful as gpr120 agonists
US9197285B2 (en) * 2012-12-20 2015-11-24 Deere & Company Methods and apparatus for ameliorating signal reception
WO2019089868A1 (en) * 2017-11-03 2019-05-09 Bristol-Myers Squibb Company Diazaspiro rock inhibitors

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3256276A (en) 1961-02-17 1966-06-14 Geschickter Fund Med Res Substituted spiroimides
FR2816940A1 (fr) 2000-11-23 2002-05-24 Lipha Derives de 4-(biphenylcarbonylamino)-piperidine, compositions les contenant et leur utilisation
EP1542667B1 (en) * 2002-07-24 2012-03-07 PTC Therapeutics, Inc. Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
EP1556046A1 (en) * 2002-10-23 2005-07-27 Janssen Pharmaceutica N.V. Phenylpiperidines and phenylpyrrolidines as histamine h3 receptor modulators
DE10306250A1 (de) * 2003-02-14 2004-09-09 Aventis Pharma Deutschland Gmbh Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7223788B2 (en) 2003-02-14 2007-05-29 Sanofi-Aventis Deutschland Gmbh Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
JP4524550B2 (ja) 2003-08-19 2010-08-18 オイレス工業株式会社 摺動部材用樹脂組成物および摺動部材
JP4765627B2 (ja) 2003-09-22 2011-09-07 Ｍｓｄ株式会社 新規ピペリジン誘導体
WO2006107661A1 (en) * 2005-04-01 2006-10-12 Eli Lilly And Company Histamine h3 receptor agents, preparation and therapeutic uses
AU2006322060A1 (en) 2005-12-05 2007-06-14 Incyte Corporation Lactam compounds and methods of using the same
JP2009519293A (ja) * 2005-12-16 2009-05-14 エフ．ホフマン−ラ ロシュ アーゲー Ｈ３レセプター調節剤としてのピロロ［２，３−ｂ］ピリジン誘導体
AU2007214709A1 (en) * 2006-02-15 2007-08-23 Sanofi-Aventis Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
US20080247964A1 (en) 2006-05-08 2008-10-09 Yuelian Xu Substituted azaspiro derivatives
JP2009544579A (ja) 2006-06-29 2009-12-17 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 置換ベンジルアミン化合物
JP5224543B2 (ja) * 2007-05-18 2013-07-03 興和株式会社 新規なスピロオキシインドール化合物及びこれを含有する医薬
CL2008001839A1 (es) 2007-06-21 2009-01-16 Incyte Holdings Corp Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades.
WO2009039431A2 (en) * 2007-09-21 2009-03-26 Neurogen Corporation Substituted aryl-fused spirocyclic amines
CA2702834C (en) * 2007-10-17 2013-01-15 Sanofi-Aventis Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof
AU2008312638B2 (en) * 2007-10-17 2013-05-16 Sanofi-Aventis Substituted N-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
MY151348A (en) 2007-10-17 2014-05-15 Sanofi Aventis Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
CA2743584A1 (en) 2008-11-23 2010-05-27 Pfizer Inc. Lactams as beta secretase inhibitors
AR074467A1 (es) 2008-12-05 2011-01-19 Sanofi Aventis Tetrahidropiran espiro pirrolidinonas y piperidinonas sustituidas, composiciones farmaceuticas que las contienen y uso de las mismas en el tratamiento y/o prevencion de enfermedades del snc ,tales como alzheimer y parkinson, entre otras.

Also Published As

Publication number Publication date
PE20120261A1 (es) 2012-04-04
WO2010065803A1 (en) 2010-06-10
JP5538421B2 (ja) 2014-07-02
MX2011004939A (es) 2011-05-25
TN2011000233A1 (en) 2012-12-17
ECSP11011108A (es) 2011-11-30
TWI481609B (zh) 2015-04-21
CA2745721C (en) 2013-09-24
EP2373652A1 (en) 2011-10-12
CN102239168B (zh) 2014-03-12
CN102239168A (zh) 2011-11-09
CR20110294A (es) 2011-09-21
CO6390058A2 (es) 2012-02-29
AR074466A1 (es) 2011-01-19
KR20110100639A (ko) 2011-09-14
US8227481B2 (en) 2012-07-24
CA2745721A1 (en) 2010-06-10
ES2441221T3 (es) 2014-02-03
RU2011127401A (ru) 2013-01-10
US20120258979A1 (en) 2012-10-11
AU2009322248A1 (en) 2011-06-23
EP2373652B1 (en) 2013-10-09
ZA201103448B (en) 2012-01-25
KR101687216B1 (ko) 2016-12-16
NZ593151A (en) 2012-11-30
IL213290A (en) 2014-01-30
JP2012511012A (ja) 2012-05-17
TW201036974A (en) 2010-10-16
IL213290A0 (en) 2011-07-31
US8604046B2 (en) 2013-12-10
US20110257213A1 (en) 2011-10-20
DK2373652T3 (da) 2014-01-20
AU2009322248B2 (en) 2015-07-16
MA32943B1 (fr) 2012-01-02

Similar Documents

Publication Publication Date Title
ZA201103448B (en) Substituted piperidine spiro pyrrolidinone and piperidinones used as h3 modulators
IL212497A0 (en) Heterocyclic gamma secretase modulators
PL2262785T3 (pl) Pochodne benzofuranowe jako modulatory FXR
EP2336109A4 (en) NOVEL PYRROLINONE DERIVATIVE AND DRUG COMPOSITION CONTAINING THE SAME
ZA201007816B (en) Novel substituted pyridin-2-ones and pyridazin-3-ones
ZA201006159B (en) Pyrrolidinone glucokinase activators
EP2433167A4 (en) COMPACT ELECTROOPTICAL MODULATOR
PL2615085T3 (pl) Pochodne pirydynowe jako modulatory CFTR
ZA200903746B (en) Biphenyl-substituted spirocyclic ketoenols
IL225214A0 (en) Piperidinyl-converted lactams as gpr119 modulators
IL208899A0 (en) Substituted gamma lactams as therapeutic agents
SI2176220T1 (sl) Pirolidin-2-onski derivati kot modulatorji androgenskih receptorjev
ZA201006329B (en) Pyrrolidine derivatives
ZA201209605B (en) Piperidinyl-substituted lactams as gpr119 modulators
IL211676A0 (en) Pyrrolidine n-benzyl derivatives
ZA201108117B (en) Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators
EP2349067A4 (en) DENTAL BRIDGE
IL213346A0 (en) Dihydropyridone amides as p2x7 modulators
IL218696A0 (en) 2-oxo-1- pyrrolidinyl imidazothiadiazole derivatives
IL193086A (en) Non-linear clock
IL213352A0 (en) Dihydropyridone amides as p2x7 modulators
ZA201104310B (en) Pyrrolidines
IL213417A0 (en) Dihydropyridone amides as p2x7 modulators
GB2477885B (en) Non-linear optical device
HK1162514A (en) Substituted piperidine spiro pyrrolidinone and piperidinones used as h3 modulators